We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin's (NUS) Effective Growth Efforts & Product Launches Aid
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) looks well placed, courtesy of focus on growth efforts like the recently unveiled Nu Vision 2025. The company is also benefiting from technology advancements and well-strategized product launches.
Let’s discuss this in detail.
Factors Working in Nu Skin’s Favor
The company is optimistic about its Nu Vision 2025 strategy to become the world’s leading integrated beauty and wellness company driven by a dynamic affiliate opportunity platform. The strategy is based around key strategic imperatives like EmpowerMe personalized beauty and wellness strategy with connected beauty devices, affiliate-powered social commerce business model and the expansion of the digital platform. The company’s EmpowerMe strategy helps in empowering affiliates to attract, connect and nurture consumers. The strategy is designed to improve product consumption, attract new customers as well as affiliates, grow recurring revenues while increasing lifetime value.
Image Source: Zacks Investment Research
With the help of advanced technology and well-strategized product programs, Nu Skin tries to capture greater market share and maintain growth momentum. The company’s long-term strategies stand on three key pillars — Products, Programs and Platforms. Under the company’s beauty products category, ageLOC Spa systems and ageLOC LumiSpa skin treatment and cleansing device delivered impressive results in 2021. The company’s ageLOC beauty products contributed 48% to its beauty product category revenues and 26% to total revenues in 2021. Under the wellness category, its three top-selling products were LifePak nutritional supplements, ageLOC Youth nutritional supplements and ageLOC TR90 weight management and body shaping system in 2021. During the second half of 2021 and continuing into 2022, the company is launching the Beauty Focus Collagen+ skincare supplement and ageLOC Meta nutritional supplement, which aids metabolic health.
The company has been successfully launching innovative beauty devices, which has now become an important part of its growth. In 2022, management expects to roll out two connected “input/output” devices. The devices will accumulate data to provide insights into consumer behavior, aiding the company to provide enhanced personalized experiences for consumers. Apart from product launches, Nu Skin’s well-knit product strategies and customer retention programs have been driving growth in several market locations. The company has also been executing cost-control measures to boost its profit scope.
Is all Rosy for Nu Skin?
Nu Skin delivered fourth-quarter 2021 results, with the top and the bottom line declining year over year. Sales leaders were down 13% to 61,515.Nu Skin’s customer base declined 12% to 1,367,559. A decline in customers and sales leaders can mainly be attributed to ongoing softness in Mainland China business, pandemic-related operational disruptions in Southeast Asia as well as economic challenges in Latin America. Nu Skin highlighted that many of its Asian markets like Mainland China continue to face strict lockdowns as well as restrictions on in-person sales events and promotional activities
In fact, the company projects revenues of $590-$560 million that include unfavorable currency impacts of 2-3% for first-quarter 2022. The projection suggests a decline of 13-17% from the year-ago quarter’s level. The company’s quarterly earnings per share (EPS) is anticipated between 75 and 65 cents, indicating an 18-28% slump from the year-ago quarter’s levels.
Nevertheless, we believe that the abovementioned upsides bode well for the long term and are likely to help this Zacks Rank #3 (Hold) company remain in investors’ good books. Shares of Nu Skin have increased 8.1% in the past six months compared with the industry’s decline of 38.4%.
Inter Parfums develops, manufactures and distributes prestige perfumes and cosmetics. It currently sports a Zacks Rank #1 (Strong Buy). Inter Parfums has a trailing four-quarter earnings surprise of 46.7%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for IPAR’s current financial year sales and EPS suggests growth of 10.9% and 9.8%, respectively, from the year-ago period’s figures.
Pilgrim’s Pride, which produces, processes, markets and distributes fresh, frozen, and value-added chicken and pork products, sports a Zacks Rank #1. PPC has a trailing four-quarter earnings surprise of 24.9%, on average.
The Zacks Consensus Estimate for Pilgrim’s Pride’s current financial-year EPS suggests growth of 19.7% from the year-ago reported number.
Flowers Foods, the producer and marketer of packaged bakery products, currently carries a Zacks Rank #2 (Buy). FLO has a trailing four-quarter earnings surprise of 9%, on average.
The Zacks Consensus Estimate for Flowers Foods’ current financial-year sales and EPS suggests growth of 7.2% and 4%, respectively, from the year-ago reported figure.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nu Skin's (NUS) Effective Growth Efforts & Product Launches Aid
Nu Skin Enterprises, Inc. (NUS - Free Report) looks well placed, courtesy of focus on growth efforts like the recently unveiled Nu Vision 2025. The company is also benefiting from technology advancements and well-strategized product launches.
Let’s discuss this in detail.
Factors Working in Nu Skin’s Favor
The company is optimistic about its Nu Vision 2025 strategy to become the world’s leading integrated beauty and wellness company driven by a dynamic affiliate opportunity platform. The strategy is based around key strategic imperatives like EmpowerMe personalized beauty and wellness strategy with connected beauty devices, affiliate-powered social commerce business model and the expansion of the digital platform. The company’s EmpowerMe strategy helps in empowering affiliates to attract, connect and nurture consumers. The strategy is designed to improve product consumption, attract new customers as well as affiliates, grow recurring revenues while increasing lifetime value.
Image Source: Zacks Investment Research
With the help of advanced technology and well-strategized product programs, Nu Skin tries to capture greater market share and maintain growth momentum. The company’s long-term strategies stand on three key pillars — Products, Programs and Platforms. Under the company’s beauty products category, ageLOC Spa systems and ageLOC LumiSpa skin treatment and cleansing device delivered impressive results in 2021. The company’s ageLOC beauty products contributed 48% to its beauty product category revenues and 26% to total revenues in 2021. Under the wellness category, its three top-selling products were LifePak nutritional supplements, ageLOC Youth nutritional supplements and ageLOC TR90 weight management and body shaping system in 2021. During the second half of 2021 and continuing into 2022, the company is launching the Beauty Focus Collagen+ skincare supplement and ageLOC Meta nutritional supplement, which aids metabolic health.
The company has been successfully launching innovative beauty devices, which has now become an important part of its growth. In 2022, management expects to roll out two connected “input/output” devices. The devices will accumulate data to provide insights into consumer behavior, aiding the company to provide enhanced personalized experiences for consumers. Apart from product launches, Nu Skin’s well-knit product strategies and customer retention programs have been driving growth in several market locations. The company has also been executing cost-control measures to boost its profit scope.
Is all Rosy for Nu Skin?
Nu Skin delivered fourth-quarter 2021 results, with the top and the bottom line declining year over year. Sales leaders were down 13% to 61,515.Nu Skin’s customer base declined 12% to 1,367,559. A decline in customers and sales leaders can mainly be attributed to ongoing softness in Mainland China business, pandemic-related operational disruptions in Southeast Asia as well as economic challenges in Latin America. Nu Skin highlighted that many of its Asian markets like Mainland China continue to face strict lockdowns as well as restrictions on in-person sales events and promotional activities
In fact, the company projects revenues of $590-$560 million that include unfavorable currency impacts of 2-3% for first-quarter 2022. The projection suggests a decline of 13-17% from the year-ago quarter’s level. The company’s quarterly earnings per share (EPS) is anticipated between 75 and 65 cents, indicating an 18-28% slump from the year-ago quarter’s levels.
Nevertheless, we believe that the abovementioned upsides bode well for the long term and are likely to help this Zacks Rank #3 (Hold) company remain in investors’ good books. Shares of Nu Skin have increased 8.1% in the past six months compared with the industry’s decline of 38.4%.
Looking for Solid Staple Stocks? Check These
Some other better-ranked stocks are Inter Parfums, Inc. (IPAR - Free Report) , Pilgrim’s Pride (PPC - Free Report) and Flowers Foods (FLO - Free Report) .
Inter Parfums develops, manufactures and distributes prestige perfumes and cosmetics. It currently sports a Zacks Rank #1 (Strong Buy). Inter Parfums has a trailing four-quarter earnings surprise of 46.7%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for IPAR’s current financial year sales and EPS suggests growth of 10.9% and 9.8%, respectively, from the year-ago period’s figures.
Pilgrim’s Pride, which produces, processes, markets and distributes fresh, frozen, and value-added chicken and pork products, sports a Zacks Rank #1. PPC has a trailing four-quarter earnings surprise of 24.9%, on average.
The Zacks Consensus Estimate for Pilgrim’s Pride’s current financial-year EPS suggests growth of 19.7% from the year-ago reported number.
Flowers Foods, the producer and marketer of packaged bakery products, currently carries a Zacks Rank #2 (Buy). FLO has a trailing four-quarter earnings surprise of 9%, on average.
The Zacks Consensus Estimate for Flowers Foods’ current financial-year sales and EPS suggests growth of 7.2% and 4%, respectively, from the year-ago reported figure.